Toru Katsumata, Ph.D.

Asahi Kasei Corporation, Japan

Poster(s):

• (M1430-04-19) Facile Dual-Drug Delivery System Based on In Situ Gelling Nanosuspension Formulation of Water-Insoluble Cyclic Peptides
  Monday, October 17, 2022

  2:30 PM – 3:30 PM ET

• (M1030-01-01) HA Nanogel/Spike Protein Complex Induces One-Year Persistent Antibody Production
  Monday, October 17, 2022

  10:30 AM – 11:30 AM ET

• (T1230-03-16) How to Improve in Solubility of Water-Insoluble Cyclic Peptide with HA Nanogel : Over 100,000-Fold Solubilization
  Tuesday, October 18, 2022

  12:30 PM – 1:30 PM ET